Strategic Partnerships Pursue collaboration with academic and research institutions leveraging the Louisiana State University license to co-develop immunomodulatory herpes vaccines, presenting opportunities for joint funding, clinical studies, and translational research services.

Clinical Leadership Leverage recent CMO appointment and advisory board leadership to position Rational Vaccines as a science-driven partner for clinical development services, medical communications, and regulatory strategy consulting aimed at accelerating preclinical-to-clinical transitions.

Early-Stage Targeting Focus outreach on biotech and pharmaceutical firms with immunology expertise seeking herpes-related solutions, offering preclinical services, assay development, and platform collaboration to advance novel immunomodulatory vaccine candidates.

Funding & Access Highlight existing funding and modest revenue as a basis for co-investment opportunities, grants alignment, and private partnerships with larger biotech players seeking risk-sharing ventures in infectious disease vaccines.

Digital Footprint Utilize accessible digital presence and technology stack (cloud, analytics, web, tracking) to propose data management, cloud-based collaboration, and analytics outsourcing services to support preclinical vaccine research and regulatory documentation.